Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension

Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M

(2013), Circulation, 128(2), 132-40

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study

Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C

(2013), Eur J Heart Fail, 15(11), 1236-44

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)

Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASIS-HF Investigators

(2013), J Am Coll Cardiol, 62(17), 1585-93

Renal sympathetic nerve ablation for treatment-resistant hypertension

Krum H, Schlaich M, Sobotka P

(2013), Br J Clin Pharmacol, 76(4), 495-503

Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial

Birnie D, Lemke B, Aonuma K, Krum H, Lee KL, Gasparini M, Starling RC, Milasinovic G, Gorcsan J 3rd, Houmsse M, Abeyratne A, Sambelashvili A, Martin DO

(2013), Heart Rhythm, 10(9), 1368-74

Diuretic use in heart failure and outcomes

von Lueder TG, Atar D, Krum H

(2013), Clin Pharmacol Ther, 94(4), 490-8

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

Collier TJ, Pocock SJ, McMurray JJ, Zannad F, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B

(2013), Eur Heart J, 34(36), 2823-9

New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation

Kanai T, Krum H

(2013), Rev Esp Cardiol, 66(9), 734-40

Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE

Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ; ATMOSPHERE Investigators

(2013), Eur J Heart Fail, 15(11), 1205-7

Management of heart failure

Krum H, Driscoll A

(2013), Med J Aust, 199(5), 334-9

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex

Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J; EchoCRT Study Group

(2013), N Engl J Med, 369(15), 1395-405

The elephant in the room of hypertension treatment: author reply

Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H

(2013), Intern Med J, 43(9), 1052-3

International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension

Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsi

(2013), J Am Coll Cardiol, 62(22), 2031-45

How does renal denervation lower blood pressure and when should this technique be considered for the treatment of hypertension?

Leong KT, Krum H

(2013), Curr Cardiol Rep, 15(11), 414

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Stewart S, Krum H

(2013), Int J Cardiol, 169(2), 133-8

3',4'-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathy

Williams SJ, Zammit SC, Cox AJ, Shackleford DM, Morizzi J, Zhang Y, Powell AK, Gilbert RE, Krum H, Kelly DJ

(2013), Bioorg Med Chem Lett, 23(24), 6868-73

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study

Shen L, Shah BR, Reyes EM, Thomas L, Wojdyla D, Diem P, Leiter LA, Charbonnel B, Mareev V, Horton ES, Haffner SM, Soska V, Holman R, Bethel MA, Schaper F, Sun JL, McMurray JJ, Califf RM, Krum H

(2013), Br Med J, 347, f6745

The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction

Lekawanvijit S, Kumfu S, Wang BH, Manabe M, Nishijima F, Kelly DJ, Krum H, Kompa AR

(2013), PLoS One, 8(12), e83687

The imaging and classification of severe pelvic ring fractures: experiences from two level 1 trauma centres

Gabbe BJ, Esser M, Bucknill A, Russ MK, Hofstee DJ, Cameron PA, Handley C, de Steiger R

(2013), Bone Joint J, 95-B(10), 1396-401

Multiple femoral and tibial avulsion fractures in a skeletally mature patient secondary to knee dislocation: a case report

Broadhead ML, Lim HK, Ek ETH, Chia A

(2013), JBJS Case Connector, 3(3), e89

435 436 437 438 439